Quote:
Originally Posted by fmichael
Results: A total of 656 patients with CRPS of at least 1-year duration were evaluated. The average age of all participants was 37.5 years, with disease duration varying from 1 to 46 years. The majority of participants were white (96%). A total of 80.3% were females. None of the patients in this study demonstrated spontaneous remission of their symptoms. The pain in these patients was refractory showing only modest improvement with most current therapies.
Discussion: This study shows that although CRPS is a progressive disease, after 1 year, the majority of the signs and symptoms were well developed and although many variables worsen over the course of the illness, the majority demonstrated only moderate increases with disease duration. [/INDENT]
Check it out.
Mike
|
Dr. Schwartzman also mentioned that the use of ketamine in both subanesthetic and anesthetic doses and immune modulation with thalidomide or lenalidomide have been demostrated to be effective in patients who have had RSD for a short time and for those who have had it for more than 5 years.
It should be noted that these are the ONLY treatments that Schwartzman listed as showing any promise for us.